Literature DB >> 11133085

A solid-phase approach to analogues of the antibiotic mureidomycin.

A Bozzoli1, W Kazmierski, G Kennedy, A Pasquarello, A Pecunioso.   

Abstract

A library of 80 analogues of the antibacterial compound mureidomycin was prepared using solid-phase chemistry techniques.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11133085     DOI： 10.1016/s0960-894x(00)00560-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  7 in total

1.  Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library.

Authors:  Dianqing Sun; Victoria Jones; Elizabeth I Carson; Robin E B Lee; Michael S Scherman; Michael R McNeil; Richard E Lee
Journal:  Bioorg Med Chem Lett       Date:  2007-10-04       Impact factor: 2.823

Review 2.  Uridine natural products: Challenging targets and inspiration for novel small molecule inhibitors.

Authors:  Christine A Arbour; Barbara Imperiali
Journal:  Bioorg Med Chem       Date:  2020-07-30       Impact factor: 3.641

3.  Efficient microwave-assisted solid phase coupling of nucleosides, small library generation and mild conditions for release of nucleoside derivatives.

Authors:  Hanumantharao Paritala; Yuta Suzuki; Kate S Carroll
Journal:  Tetrahedron Lett       Date:  2013-04-01       Impact factor: 2.415

4.  A Modular Approach to Phosphoglycosyltransferase Inhibitors Inspired by Nucleoside Antibiotics.

Authors:  Marthe T C Walvoort; Vinita Lukose; Barbara Imperiali
Journal:  Chemistry       Date:  2015-12-10       Impact factor: 5.236

5.  Solid-phase synthesis of a thymidinyl dipeptide urea library.

Authors:  Dianqing Sun; Richard E Lee
Journal:  J Comb Chem       Date:  2007-04-07

6.  Backbone-Anchoring, Solid-Phase Synthesis Strategy To Access a Library of Peptidouridine-Containing Small Molecules.

Authors:  Christine A Arbour; Barbara Imperiali
Journal:  Org Lett       Date:  2022-03-10       Impact factor: 6.072

7.  Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis.

Authors:  Anh T Tran; Emma E Watson; Venugopal Pujari; Trent Conroy; Luke J Dowman; Andrew M Giltrap; Angel Pang; Weng Ruh Wong; Roger G Linington; Sebabrata Mahapatra; Jessica Saunders; Susan A Charman; Nicholas P West; Timothy D H Bugg; Julie Tod; Christopher G Dowson; David I Roper; Dean C Crick; Warwick J Britton; Richard J Payne
Journal:  Nat Commun       Date:  2017-03-01       Impact factor: 14.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.